Abstract
Background:Recent studies suggest that blockade of the NLRP3 (cryopyrin) inflammasome interleukin 1β (IL1β) pathway may offer a new treatment strategy for gout.Objective:To explore the potential utility of rilonacept (IL1 Trap)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have